The Penn State Cancer Institute is now the first and only oncology center in central Pennsylvania to offer patients CAR T-cell therapy, a cutting-edge treatment that has been successful in treating a common type of lymphoma. read more
Penn State’s 2018-19 general support appropriation increased by 3 percent — or roughly $6.9 million — as the University’s non-preferred appropriations bill today (June 22) passed the General Assembly as part of Pennsylvania’s $32.7 billion budget package. read more